Overview

A Randomized Acceptability and Safety Study of the Transfer From Subutex to Suboxone in Opioid- Dependent Subjects (Study P04843)(COMPLETED)

Status:
Completed
Trial end date:
2009-05-01
Target enrollment:
Participant gender:
Summary
Post-marketing commitment to the European Medicines Agency to conduct a prospective, controlled study of the transfer from Subutex to Suboxone.
Phase:
Phase 4
Details
Lead Sponsor:
Indivior Inc.
Treatments:
Buprenorphine
Buprenorphine, Naloxone Drug Combination
Naloxone